SenseLab 
logo Brain Pharmacology Database User:Public
[Data]
Pathological mechanism
NameAbeta-derived diffusible ligands (ADDLs) attack synapses at or near NMDA receptors
Description
Hypothesis
Extracelular pathological element
Abeta-derived diffusible ligands (ADDLs) show other
Intracelular pathological element
Pathological action
Induces show other
Process
Synapse Loss show other
Process action
Binds at or near show other
Transmitter(s)
Receptor(s)
NMDA show other
Channel(s)
Pharmacological Agent
Pharmacological Action
Brain region
Neuron
Cell model
Cellular compartment
PubMed ID18165846
Citation
AlzWeb
NotesADDL binding instigates synapse loss, oxidative damage, and AD-type tau hyperphosphorylation.ADDLs act as pathogenic gain-of-function ligands that target particular synapses, binding to synaptic spines at or near NMDA receptors. Subsequent ADDL-induced abnormalities in spine morphology and synaptic receptor composition. Viola, K. L., Velasco, P. T., & Klein, W. L. (2008). Why alzheimer's is a disease of memory: The attack on synapses by A beta oligomers (addls). The Journal of Nutrition, Health & Aging, 12(1), 51S-57S.
Pathology
Alzheimer show other
Stage
Early show other
Question
Claim

Other categories referring to "Abeta-derived diffusible ligands (ADDLs) attack synapses at or near NMDA receptors"

 
Revisions:4
Last time:11/24/2008 12:29:55 PM
Reviewer:Pradeep Mutalik
Owner:Pradeep Mutalik

This database was supported by the Human Brain Project (NIDCD, NIMH, NIA, NICD, NINDS) and MURI (Multidisciplinary University Research Initiative). It is now supported by RO1 DC 009977 from the National Institute for Deafness and other Communication Disorders.
Link Graphic to NIF website Human Brain Project Yale Center for Medical Informatics Questions, comments, problems? Email the Database Administrator
This site is Copyright 2011, Yale Center for Medical Informatics
National Institutes of Health Department of Health and Human Services